GOSS vs MRO
Gossamer Bio Inc (GOSS) versus MRO (MRO) — a side-by-side from cached financials, not a winner call.
Gossamer Bio Inc (GOSS) is a biotechnology company listed on US.
MRO (MRO) common stock.
Latest reported GOSS revenue for 2026-06-30 was $26.2M. Net income was -$29.8M. Revenue was up 54.5% from 2026-03-31 to 2026-06-30. GOSS currently screens at market cap $47.0M.
MRO does not have a complete income-statement cache yet.
GOSS currently screens at market cap $47.0M.
Not investment advice. Open the GOSS and MRO stock pages for the full models.
Not investment advice.